Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Inc. (BNTC) is a healthcare company (biotechnology) based in the United States. The share price is $8.19, down 4.10% on the day, which values the company at $295.81M. Price as of 17 Nov 2026, 17:31 UTC, from Yahoo Finance.

Key facts

Share price
$8.19−4.10% today
Market value
$295.81M
200-week average
$9.009% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Benitec Biopharma Inc. in more detail

BNTC trades at -0.9× next year's expected earnings. It sits 9% below its 200-week average of $9.00.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold BNTC, including Peter Kolchinsky (0.2% of the portfolio).

Superinvestors holding BNTC

1 of the investors tracked here report a position in their latest 13F filing.

Benitec Biopharma Inc. (BNTC): questions and answers

What is Benitec Biopharma Inc.'s market cap?

Benitec Biopharma Inc. is valued at $295.81M at a share price of $8.19.

Is BNTC above its 200-week moving average?

No. BNTC is 9.0% below its 200-week average of $9.00. Long-term investors watch that line because strong companies rarely trade below it for long.

Does BNTC pay a dividend?

Benitec Biopharma Inc. does not currently pay a regular dividend.

Which famous investors own BNTC?

In their latest quarterly filings, Peter Kolchinsky (0.2% of the portfolio) hold BNTC. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

When does Benitec Biopharma Inc. report earnings next?

Benitec Biopharma Inc.'s next earnings report is expected on February 11, 2027. The date comes from the market data feed and companies do move it.

Cite this page

Funkfolio, “Benitec Biopharma Inc. (BNTC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BNTC

Underlying data: Yahoo Finance; company filings with the SEC.